CAROLYN BLACKBURN: Open Payments
NPI 1902336431 · CHILLICOTHE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 8 companies in 2025. Trend: 2023 $259 · 2024 $267 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $98 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| KYOWA KIRIN, INC. | 1 | $28 |
| Viatris Specialty LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: INGREZZA, Ozempic, VRAYLAR, XIFAXAN, AIRSUPRA, CRYSVITA, YUPELRI, Rybelsus.
Industry payments across MO — which companies pay providers there.
